» Articles » PMID: 32376475

A Western Diet Impairs CNS Energy Homeostasis and Recovery After Spinal Cord Injury: Link to Astrocyte Metabolism

Overview
Journal Neurobiol Dis
Specialty Neurology
Date 2020 May 8
PMID 32376475
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

A diet high in fat and sucrose (HFHS), the so-called Western diet promotes metabolic syndrome, a significant co-morbidity for individuals with spinal cord injury (SCI). Here we demonstrate that the spinal cord of mice consuming HFHS expresses reduced insulin-like growth factor 1 (IGF-1) and its receptor and shows impaired tricarboxylic acid cycle function, reductions in PLP and increases in astrogliosis, all prior to SCI. After SCI, Western diet impaired sensorimotor and bladder recovery, increased microgliosis, exacerbated oligodendrocyte loss and reduced axon sprouting. Direct and indirect neural injury mechanisms are suggested since HFHS culture conditions drove parallel injury responses directly and indirectly after culture with conditioned media from HFHS-treated astrocytes. In each case, injury mechanisms included reductions in IGF-1R, SIRT1 and PGC-1α and were prevented by metformin. Results highlight the potential for a Western diet to evoke signs of neural insulin resistance and injury and metformin as a strategy to improve mechanisms of neural neuroprotection and repair.

Citing Articles

Spinal cord injury-induced metabolic impairment and steatohepatitis develops in non-obese rats and is exacerbated by premorbid obesity.

Goodus M, Alfredo A, Carson K, Dey P, Pukos N, Schwab J Exp Neurol. 2024; 379:114847.

PMID: 38852834 PMC: 11874686. DOI: 10.1016/j.expneurol.2024.114847.


Dual-directional regulation of spinal cord injury and the gut microbiota.

Cui Y, Liu J, Lei X, Liu S, Chen H, Wei Z Neural Regen Res. 2023; 19(3):548-556.

PMID: 37721283 PMC: 10581592. DOI: 10.4103/1673-5374.380881.


The Impact of Intermittent Hypoxia on Metabolism and Cognition.

Shobatake R, Ota H, Takahashi N, Ueno S, Sugie K, Takasawa S Int J Mol Sci. 2022; 23(21).

PMID: 36361741 PMC: 9654766. DOI: 10.3390/ijms232112957.


Glial-neuron crosstalk in health and disease: A focus on metabolism, obesity, and cognitive impairment.

Henn R, Noureldein M, Elzinga S, Kim B, Savelieff M, Feldman E Neurobiol Dis. 2022; 170:105766.

PMID: 35584728 PMC: 10071699. DOI: 10.1016/j.nbd.2022.105766.


Nimodipine Exerts Beneficial Effects on the Rat Oligodendrocyte Cell Line OLN-93.

Boltz F, Enders M, Feigenspan A, Kirchner P, Ekici A, Kuerten S Brain Sci. 2022; 12(4).

PMID: 35448007 PMC: 9029615. DOI: 10.3390/brainsci12040476.


References
1.
Ness J, Mitchell N, Wood T . IGF-I and NT-3 signaling pathways in developing oligodendrocytes: differential regulation and activation of receptors and the downstream effector Akt. Dev Neurosci. 2003; 24(5):437-45. DOI: 10.1159/000069050. View

2.
CARSON M, Behringer R, Brinster R, McMorris F . Insulin-like growth factor I increases brain growth and central nervous system myelination in transgenic mice. Neuron. 1993; 10(4):729-40. DOI: 10.1016/0896-6273(93)90173-o. View

3.
Bosi E . Metformin--the gold standard in type 2 diabetes: what does the evidence tell us?. Diabetes Obes Metab. 2009; 11 Suppl 2:3-8. DOI: 10.1111/j.1463-1326.2008.01031.x. View

4.
Salkovic-Petrisic M, Knezovic A, Hoyer S, Riederer P . What have we learned from the streptozotocin-induced animal model of sporadic Alzheimer's disease, about the therapeutic strategies in Alzheimer's research. J Neural Transm (Vienna). 2012; 120(1):233-52. DOI: 10.1007/s00702-012-0877-9. View

5.
Frederick T, Wood T . IGF-I and FGF-2 coordinately enhance cyclin D1 and cyclin E-cdk2 association and activity to promote G1 progression in oligodendrocyte progenitor cells. Mol Cell Neurosci. 2004; 25(3):480-92. DOI: 10.1016/j.mcn.2003.11.015. View